glucosidase/비만증

This invention relates to novel 1,4-di-deoxy-1,4-imino-D-arabinitol derivatives, to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes. More specifically this invention relates to novel N-glycosyl derivatives of

BACKGROUND Glucosidase enzymes are involved in several biological processes such as the intestinal digestion, the biosynthesis of glycoproteins and the lysosomal catabolism of the glycoconjugates (Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of

CROSS REFERENCE TO RELATED APPLICATIONS: This application is the National Stage of International Application No. PCT/JP2010/058624, filed May 21, 2010, and claims benefit of Japanese Application No. 2009-123585 filed May 21, 2009, which are herein incorporated by reference in their

TECHNICAL FIELD The present invention relates to an anti-obesity agent containing a benzotropolone ring-containing compound. BACKGROUND ART Obesity is one of the most significant diseases in modern society and the main factor of obesity is excessive intake of fat. Excessive intake of fat is known to

TECHNICAL FIELD The present invention relates to methods for inhibiting of alpha-glucosidases in subjects. In particular, the invention relates to the use of human pancreatic alpha-amylase inhibitors to reduce starch hydrolysis in subjects and further relates to the treatment of conditions

OBJECTS OF THE INVENTION It is an object of the invention to control weight in humans by ingesting acarbose with meals with food containing carbohydrates. This and other objects and advantages will become obvious from the following detailed description. THE INVENTION The invention is directed to a

This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as

This invention pertains to the use of maltosyl-isomaltooligosaccharides as a dietary supplement for birds and mammals, specifically, to promote the growth of beneficial intestinal microbes, inhibit the growth of pathogenic intestinal microbes, and for therapeutic intervention in diseases such as

This invention relates to a novel inosose compound represented by the general formula: ##STR3## wherein X.sup.1 and X.sup.2 are both halogen, X.sup.1 is hydrogen and X.sup.2 is halogen, or X.sup.1 is --SQ.sup.1 and X.sup.2 is --SQ.sup.2 (each of Q.sup.1 and Q.sup.2 is lower alkyl or Q.sup.1 and

This invention relates to a novel inosose compound represented by the general formula: ##STR3## wherein X.sup.1 and X.sup.2 are both halogen, X.sup.1 is hydrogen and X.sup.2 is halogen, or X.sup.1 is --SQ.sup.1 and X.sup.2 is --SQ.sup.2 (each of Q.sup.1 and Q.sup.2 is lower alkyl or Q.sup.1 and

BACKGROUND TO THE INVENTION The present invention provides two novel polyhydroxycyclopentane derivatives which have certain valuable biological activities and provides methods of preparing these compounds as well as methods and compositions using them for therapeutic and prophylactic purposes. The

TECHNICAL FIELD The present invention relates generally to nutrition and more particularly to a method of use and nutritional compositions containing .alpha.-glucosidase inhibitors, and more specifically Touchi Extract. BACKGROUND OF THE INVENTION Touchi Extract (TE) is a water-extract powder of

FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to

FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to

FIELD OF INVENTION In general, the present invention relates to pharmaceutical compositions, and more particularly, to pharmaceutical compositions for the treatment of diabetes mellitus using combination therapy. BACKGROUND OF THE INVENTION Diabetes mellitus is a term generally used to refer to